Genetic polymorphisms influencing antihypertensive drug responses
<p dir="ltr">Hypertension is a major contributor to cardiovascular disease and its associated morbidity and mortality. The low efficacy observed with some anti‐hypertensive therapies has been attributed partly to inter‐individual genetic variability. This paper reviews the major find...
Saved in:
| Main Author: | Jana El Cheikh (22330738) (author) |
|---|---|
| Other Authors: | Fouad Hamed (22330741) (author), Hana Rifi (22330744) (author), Ali H. Dakroub (22303819) (author), Ali Hussein Eid (13355211) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
by: Yara Wanas (8744844)
Published: (2020) -
Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs
by: Mohamed A. Elrayess (21398687)
Published: (2022) -
Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction
by: Rasha Kaddoura (12506936)
Published: (2023) -
Successful Use of Intravenous B-blocker Therapy in Cardiogenic Shock Supported With Venoarterial Extracorporeal Membrane Oxygenation: A Case Series
by: Alaa Rahhal (14150403)
Published: (2022) -
Diagnostic and therapeutic challenges of BRASH syndrome
by: Fateen Ata (12217764)
Published: (2021)